Status:
UNKNOWN
Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Nephropathy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Contrast induced nephropathy (CIN) is of great concern when using contrast media in the new era of medicine. CIN is defined as 25-50% relative increase, 0.5-1 absolute increase in serum creatinin valu...
Eligibility Criteria
Inclusion
- All eligible consecutive patients who are admitted to the angiography center of university hospitals for PCI since April 2011 will be enrolled to enter the study.
Exclusion
- Serum creatinine above 1.5 mg/dl
- Frank bleeding tendency
- Those previously on pentoxifylline
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
End Date :
June 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01469624
Start Date
April 1 2011
End Date
June 1 2012
Last Update
November 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals
Shiraz, Fars, Iran